Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT04361669
  4. Details
NCT04361669 Clinical Trial

Hospice Quality Score Assessment Post Pharmacist Intervention

Cancer Clinical Trial

Official title:
Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT04361669
Other study ID # TRHC_RD_Hospice_2020
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date April 22, 2020
Est. completion date September 1, 2022

Study information
Verified date September 2022
Source Tabula Rasa HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Description:

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date September 1, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years to 88 Years
Eligibility Inclusion Criteria: Adult patients who were referred to hospice by a healthcare provider Exclusion Criteria: Patients 89 years or older

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Medication safety review
Implementation of a medication safety review using a clinical decision support system

Locations
Country Name City State
United States Tabula Rasa HealthCare Tucson Arizona

Sponsors (1)
Lead Sponsor Collaborator
Tabula Rasa HealthCare

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary National Quality Forum Score Performance metric used by hospice. Scale 0 - 100 (0=min; 100-high) 6 months
Primary Consumer Assessment of Healthcare Providers and Systems Performance metric used by hospice (0=min; 100-high) 6 months
Primary Time to refill Time to refill prescription from hospice organization (0=min; 100-high) 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases